PAREXEL appoints Larson as VP of evidence development
Friday, August 3, 2012
PAREXEL Consulting, a business unit of PAREXEL International and a global consultancy serving the biopharmaceutical and medical device industries, has appointed Leanne R. Larson as vice president of evidence development, a newly created position.
Larson brings 25 years of experience in healthcare to PAREXEL, including extensive work in pharmaceutical product development, marketing, healthcare technology and operational consulting. Prior to joining PAREXEL, she served more than 15 years in senior and strategic roles within Clinical Research Organizations. Larson has also held positions in Ernst & Young’s Life Sciences and Pharmaceuticals consulting practice, as well as at Merck‘s Health Sciences-Digestive Disease group.